Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
17.0%
% of WDNA's 91 holdings also in CANC
31.9%
% of CANC's 47 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
BLUEPRINT MEDICINES CORP. | 2.6% | 4.3% | 2.6% |
|
AGIOS PHARMACEUTICALS INC | 2.4% | 2.9% | 2.4% |
|
REGENERON PHARMACEUTICALS | 1.4% | 5.4% | 1.4% |
|
AMGEN INC | 1.4% | 1.4% | 1.4% |
|
CRISPR THERAPEUTICS AG | 1.3% | 2.5% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to CANC
|
TWIST BIOSCIENCE CORP. | 4.3% |
 |
NOVOZYMES A/S-B SHARES | 2.7% |
|
GERON CORP | 2.5% |
|
FATE THERAPEUTICS INC | 2.2% |
|
NATERA INC | 2.2% |
|
VERICEL CORPORATION | 2.1% |
|
ELI LILLY & CO | 2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.7% |
|
SAREPTA THERAPEUTICS INC | 1.7% |
|
BRIDGEBIO PHARMA, INC. | 1.6% |
WDNA Underweight Relative to CANC
 |
ASTRAZENECA PLC | -5.2% |
|
REVOLUTION MEDICINES, INC. | -4.6% |
|
GILEAD SCIENCES INC | -4.4% |
 |
ARGENX SE ADR | -4.3% |
|
INCYTE CORP | -4.2% |
|
REGENERON PHARMACEUTICALS | -4.0% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% |
|
DAIICHI SANKYO CO LTD | -3.1% |
|
EXELIXIS INC | -3.0% |
|
ILLUMINA INC | -2.9% |